Diagnosis and management of cryptococcal meningitis in HIV-infected adults
Clinical Microbiology Reviews · 20.12.2023 · 36 (4)
DOI: 10.1128/cmr.00156-22 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 20.12.2023. Verfasst von Thomas C McHale und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: HIV Infections, Meningitis, Cryptococcal. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cryptococcal meningitis is a leading cause of morbidity and mortality globally, especially in people with advanced HIV disease. Cryptococcal meningitis is responsible for nearly 20% of all deaths related to advanced HIV disease, with the burden of disease predominantly experienced by people in resource-limited countries. Major advancements in diagnostics have introduced low-cost, easy-to-use antigen tests with remarkably high sensitivity and specificity. These tests have led to improved diagnostic accuracy and are essential for screening campaigns to reduce the burden of cryptococcosis. In the last 5 years, several high-quality, multisite clinical trials have led to innovations in therapeutics that have allowed for simplified regimens, which are better tolerated and result in less intensive monitoring and management of medication adverse effects. One trial found that a shorter, 7-day course of deoxycholate amphotericin B is as effective as the longer 14-day course and that flucytosine is an essential partner drug for reducing mortality in the acute phase of disease. Single-dose liposomal amphotericin B has also been found to be as effective as a 7-day course of deoxycholate amphotericin B. These findings have allowed for simpler and safer treatment regimens that also reduce the burden on the healthcare system. This review provides a detailed discussion of the latest evidence guiding the clinical management and special circumstances that make cryptococcal meningitis uniquely difficult to treat.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
- Infectious Diseases Institute, Makerere University, Kampala, Uganda.
ORCID-Profile: Thomas C McHale, David R Boulware, Kenneth Ssebambulidde, Caleb P Skipper
Zitieren
APA
McHale, T. C., Boulware, D. R., Kasibante, J., Ssebambulidde, K., Skipper, C. P., & Abassi, M. (2023). Diagnosis and management of cryptococcal meningitis in HIV-infected adults. Clinical Microbiology Reviews, 36(4). https://doi.org/10.1128/cmr.00156-22
Vancouver
McHale TC, Boulware DR, Kasibante J, Ssebambulidde K, Skipper CP, Abassi M. Diagnosis and management of cryptococcal meningitis in HIV-infected adults. Clinical Microbiology Reviews. 2023;36(4). doi:10.1128/cmr.00156-22
BibTeX
@article{McHale2023,
author = {McHale, Thomas C and Boulware, David R and Kasibante, John and Ssebambulidde, Kenneth and Skipper, Caleb P and Abassi, Mahsa},
title = {Diagnosis and management of cryptococcal meningitis in HIV-infected adults},
journal = {Clinical Microbiology Reviews},
year = {2023},
volume = {36},
number = {4},
doi = {10.1128/cmr.00156-22}
}
EUVIMED